What is Required to Gain Approval of Lipid Altering Drugs?
Part of the Developments in Cardiovascular Medicine book series (DICM, volume 100)
In practical terms, there really are two questions:
How does one achieve approval for a drug for even the most limited indication? and
How does one get approval for the indication of preventing coronary heart disease?
KeywordsCholesterol Pancreatitis Marketing Triglyceride
Unable to display preview. Download preview PDF.
© Kluwer Academic Publishers 1989